Amyotrophic Lateral Sclerosis Research

Review examines ketamine’s possible mechanisms for treating ALS

This narrative review discusses whether ketamine could be a candidate therapy for amyotrophic lateral sclerosis (ALS). It focuses on proposed mechanisms related to sigma-1 receptors, mitochondria, protein handling, inflammation, and neuroplasticity, but it does not present new clinical trial results in people with ALS.